Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $390.3 million.

  • Integra Lifesciences Holdings' Operating Expenses rose 33.86% to $390.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 3825.7%. This contributed to the annual value of $1.6 billion for FY2024, which is 1063.38% up from last year.
  • Integra Lifesciences Holdings' Operating Expenses amounted to $390.3 million in Q3 2025, which was up 33.86% from $928.3 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Operating Expenses registered a high of $928.3 million during Q2 2025, and its lowest value of $320.1 million during Q3 2022.
  • In the last 5 years, Integra Lifesciences Holdings' Operating Expenses had a median value of $355.8 million in 2023 and averaged $389.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first crashed by 492.92% in 2022, then surged by 12038.7% in 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' Operating Expenses (Quarter) stood at $347.3 million in 2021, then dropped by 4.93% to $330.2 million in 2022, then rose by 9.33% to $361.0 million in 2023, then rose by 12.75% to $407.0 million in 2024, then dropped by 4.11% to $390.3 million in 2025.
  • Its last three reported values are $390.3 million in Q3 2025, $928.3 million for Q2 2025, and $398.2 million during Q1 2025.